A Retrospective Unicenter Study of Clinical and Inflammatory Features in Hospitalized Adults with Respiratory Syncytial Virus Infection Across Two Epidemic Waves in Catalonia, Spain

preprint OA: closed CC-BY-4.0
🔓 Open OA copy View at publisher

Abstract

Background: Respiratory syncytial virus (RSV) is a serious disease in older adults with comorbidities; however, comparative data across epidemic waves, both clinically and in terms of inflammatory profiles and their diagnostic and prognostic utility, remain limited. Methods: We conducted a retrospective study of adults hospitalized with RSV infection across two epidemic waves (2022–2023 and 2024–2025). Clinical characteristics, comorbidities, severity scores, and outcomes were collected. Serum interleukin-6 (IL-6), C-reactive protein (CRP), and hematological parameters were analyzed and compared with healthy controls. Results: A total of 152 patients were included (81 in wave 1 and 71 in wave 2). Patients in wave 2 were older and had a higher burden of comorbidities, although ICU admission and in-hospital mortality were similar across waves. RSV induced a consistent systemic inflammatory response in both waves, characterized by elevated IL-6 and CRP levels, neutrophilia, lymphopenia, and increased neutrophil-to-lymphocyte ratio, without relevant inter-wave differences. All biomarkers demonstrated good diagnostic performance. The neutrophil-to-lymphocyte ratio, showed the highest accuracy, while IL-6 exhibited excellent rule-in capacity due to perfect specificity. However, none of the evaluated biomarkers were associated with disease severity (McCabe index) or in-hospital mortality. Conclusion: RSV infection in older adults is associated with a stable inflammatory signature across epidemic waves. Although biomarkers showed strong diagnostic utility, they lacked clinical prognostic value. We suggest that disease severity is mainly driven by host-related factors, particularly comorbidities, rather than differences in inflammatory response, highlighting the need for improved preventive and risk stratification strategies in this population.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-26T02:00:01.498150+00:00
License: CC-BY-4.0